The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae after COVID-19 infection: a multinational network cohort study
Journal of the Royal Society of Medicine · 2025-07 · 118 (7) · 213-229
DOI: 10.1177/01410768251352666 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the Royal Society of Medicine, online erschienen am 08.07.2025. Verfasst von Ivan Chun Hang Lam und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Ko…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Collaborative Research Fund, Health Bureau.
Abstract (Originalsprache)
Objectives
To generate comprehensive evidence on the risk of clinical sequelae involving different organ systems over time after coronavirus disease 2019 (COVID-19) infection.
Design
Multinational retrospective cohort study.
Setting
Electronic medical records from the US, UK, France, Germany and Italy standardised to the Observational Medical Outcomes Partnership Common Data Model.
Participants
A total of 303,251 individuals with a COVID-19 infection between 1 December 2019 and 1 December 2020 and propensity score matched non-COVID-19 comparators from 22,108,925 eligible candidates. Main outcome measures Incidence of 73 clinical sequelae involving multiple organ systems including the respiratory, cardiovascular, dermatological and endocrine systems over the short- (0–6 months), medium- (6–12 months) and long-term (1–2 years) after COVID-19 infection. The hazard ratio (HR) and 95% confidence interval (95% CI) of individual disease outcomes were estimated using Cox proportional hazard regression.
Results
Individuals with COVID-19 incurred a greater risk of clinical sequelae involving multiple organ systems including respiratory (France HR 2.23, 95%CI [2.10,2.37] to Italy 13.13 [11.80,14.63]), cardiovascular (Germany 1.39 [1.30,1.50] to US 1.79 [1.74,1.85]) and dermatological (UK 1.13 [1.01,1.25] to Italy 1.77 [1.42,2.21]) disorder over the short-term. While the risk of clinical sequelae has largely subsided during the medium-term, the risk of cardiovascular- (US 1.16 [1.11,1.21], France 1.10 [1.01,1.19]) and endocrine- (US 1.18 [1.12,1.24], Germany 1.15 [1.03,1.29]) related complications may continue to persist for up to two years.
Conclusions
Through a network of multinational healthcare databases, this study generated comprehensive and robust evidence supporting the extensive multi-organ involvement of post-COVID-19 condition over the short-term period and the reduction in risk for most complications over the medium- and long-term.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
- Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford OX3 7LD, UK.
- School of Public Health, Shenzhen University Medical School, Shenzhen University, Shenzhen, China.
- The Hong Kong Jockey Club Centre for Suicide Research and Prevention, The University of Hong Kong, Hong Kong SAR, China.
- Research Department of Practice and Policy, School of Pharmacy, University College London, London WC1N 1AX, UK.
- Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London NW1 2PB, UK.
ORCID-Profile: Ivan Chun Hang Lam, Kenneth Keng Cheung Man, Eric Yuk Fai Wan, Ian Chi Kei Wong
Förderung
- Collaborative Research Fund
- Health Bureau
Zitieren
APA
Lam, I. C. H., Chai, Y., Man, K. K. C., Lau, W. C. Y., Luo, H., Lin, X., Yin, C., Chui, C. S. L., Li, X., Zhang, Q., Chan, E. W. Y., Wan, E. Y. F., & Wong, I. C. K. (2025). The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae after COVID-19 infection: a multinational network cohort study. Journal of the Royal Society of Medicine, 118(7), 213-229. https://doi.org/10.1177/01410768251352666
Vancouver
Lam ICH, Chai Y, Man KKC, Lau WCY, Luo H, Lin X, et al. The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae after COVID-19 infection: a multinational network cohort study. Journal of the Royal Society of Medicine. 2025;118(7):213-229. doi:10.1177/01410768251352666
BibTeX
@article{Lam2025,
author = {Lam, Ivan Chun Hang and Chai, Yi and Man, Kenneth Keng Cheung and Lau, Wallis Cheuk Yin and Luo, Hao and Lin, Xiaoyu and Yin, Can and Chui, Celine Sze Ling and Li, Xue and Zhang, Qingpeng and Chan, Esther Wai Yin and Wan, Eric Yuk Fai and Wong, Ian Chi Kei},
title = {The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae after COVID-19 infection: a multinational network cohort study},
journal = {Journal of the Royal Society of Medicine},
year = {2025},
volume = {118},
number = {7},
pages = {213--229},
doi = {10.1177/01410768251352666}
}
EUVIMED